BioMarin Pharmaceutical Inc
F:BM8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioMarin Pharmaceutical Inc
F:BM8
|
US |
|
L
|
Louisiana-Pacific Corp
SWB:LP3
|
US |
|
X
|
Xenia Hotels & Resorts Inc
F:0XHR
|
US |
|
A
|
Airlux Electrical Co Ltd
TPEX:4609
|
TW |
|
Asia Vital Components Co Ltd
TWSE:3017
|
TW |
|
Indo Komoditi Korpora Tbk PT
IDX:INCF
|
ID |
|
P
|
Peking University Resources (Holdings) Company Ltd
HKEX:618
|
HK |
|
Compagnie de Saint Gobain SA
F:GOBU
|
FR |
|
CPI Card Group Inc
NASDAQ:PMTS
|
US |
|
B
|
Brooker Group PCL
SET:BTC
|
TH |
|
Thungela Resources Ltd
OTC:TNGRF
|
ZA |
|
T
|
Talanx AG
DUS:TLX
|
DE |
|
Doubleview Gold Corp
XTSX:DBG
|
CA |
|
P
|
Prince Pharmaceutical Co Ltd
TPEX:6935
|
TW |
|
S
|
SyntekaBio Inc
KOSDAQ:226330
|
KR |
|
S
|
Standard Bank Group Ltd
JSE:SBK
|
ZA |
|
V
|
Visgeneer Inc
TPEX:4197
|
TW |
|
J
|
Japan Wool Textile Co Ltd
TSE:3201
|
JP |
|
A
|
Aspermont Ltd
XHAM:00W
|
AU |
|
G
|
Ggumbi Inc
KOSDAQ:407400
|
KR |
|
Hermes International SCA
F:HMI
|
FR |
|
S
|
Swiss Re AG
OTC:SSREF
|
CH |
|
T
|
Taiwan Sanyo Electric Co Ltd
TWSE:1614
|
TW |
|
Round One Corp
TSE:4680
|
JP |
Discount Rate
BM8 Cost of Equity
Discount Rate
BM8's Cost of Equity, calculated using the formula Risk-Free Rate + Beta x ERP, stands at 9.99%. The Beta, indicating the stock's volatility relative to the market, is 1.11, while the current Risk-Free Rate, based on government bond yields, is 5.22%, and the ERP, measuring the extra return over the risk-free rate required by investors, is 4.3%.
BM8 WACC
Discount Rate
BM8's Weighted Average Cost of Capital (WACC) is calculated as the weighted average of its cost of equity and cost of debt, adjusted for tax. The WACC stands at 8.92%. This includes the cost of equity at 9.99%, calculated as Risk-Free Rate + Beta x ERP, and the cost of debt at 5.42%, reflecting the interest rate on BM8's debt adjusted for tax benefits. The weight of debt in the capital structure is 23.34%.
What is BM8's discount rate?
BM8's current Cost of Equity is 9.99%, while its WACC stands at 8.92%. The selection of the appropriate discount rate is contingent on the type of cash flows being discounted.
For Equity Valuation: When valuing equity, especially in scenarios where you are discounting cash flows to equity holders (such as Net Income, Earnings Per Share (EPS), or Free Cash Flow to Equity), the Cost of Equity should be used.
For Firm Valuation: In contrast, when valuing the entire firm and discounting cash flows available to both debt and equity holders (like Free Cash Flow to the Firm), the Weighted Average Cost of Capital (WACC) is the appropriate rate.
How is Cost of Equity for BM8 calculated?
The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP).
This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk.
Here is how we calculate the cost of equity for
BM8
How is WACC for BM8 calculated?
WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company’s entire operations.
The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure.
Here is how we calculate WACC for
BM8